U.S. Venture Partners related stories
All articles and analysis
Exit watch, week of June 22, 2009M&A news briefs about venture-backed companies Dexterra, Chestnut Medical, Tzero and others
- Tzero Tech Sells Out
NDS Surgical Imaging LLC, a portfolio company of Riverside Partners, has acquired Tzero Technologies, a Sunnyvale, Calif.-based provider of ultra-wideband technology and wireless video products, according to VentureWire. The move reportedly came after Tzero failed to secure new funding. It had raised around $60 million in VC funding from firms like August Capital, CID Group, Lightspeed Venture Partners, OVP, U.S. Venture Partners and VentureTech Alliance. Its most recent round was a $17 million Series C infusion in early 2007. www.tzerotech.com
- Week in deals, June 15, 2009
Summary of tech companies and other businesses that raised financing in North America in the past week
- peHUB Wire: Monday, June 15, 2009
Random Ramblings
- peHUB Wire: Monday, June 15, 2009
Random Ramblings
- Bayhill Therapeutics Signs Licensing Deal with Genentech
Bayhill Therapeutics Inc. has signed a worldwide license agreement with Genentech Inc., for an antigen-specific immunotherapy currently in a phase I/II clinical trial in patients with type 1 diabetes. The deal includes a $25 million upfront payment in cash and stock, and could be worth up to $325 million. Bayhill had previously raised $62.75 million in VC funding, from firms like U.S. Venture Partners, Morgenthaler Ventures, De Novo Ventures, CMEA Ventures, Lilly Ventures, Latterell Venture Partners, Montreux Equity Partners, Pappas Ventures, Boston Life Science Venture Corp., Grand Cathay Venture Capital Co., PAC-LINK Bio Management Corp., Prudence Venture Investment and Vertical Group. It had planned to go public, but pulled the offering last summer.
- peHUB Wire: Tuesday, June 9, 2009
Random Ramblings